Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$11.58 +0.8%	$11.89	$4.88 ▼ $13.14	$1.68B	1.05	2.08 million shs	1.65 million shs
INO Inovio Pharmaceuticals	$1.39 -4.1%	$1.95	$1.30 ▼ $12.33	$53.18M	1.31	802,696 shs	2.58 million shs
OSUR OraSure Technologies	$3.05 +0.7%	$2.84	$2.36 ▼ $4.92	$226.64M	0.45	742,994 shs	715,993 shs
UTMD Utah Medical Products	$57.21 -0.1%	$55.30	$51.26 ▼ $77.33	$185.99M	0.28	19,581 shs	11,129 shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	+0.78%	+5.42%	-5.16%	+18.77%	+7.52%
INO Inovio Pharmaceuticals	-4.14%	-3.14%	-38.22%	-13.66%	-85.02%
OSUR OraSure Technologies	+0.66%	-0.97%	+2.01%	+4.10%	-27.03%
UTMD Utah Medical Products	-0.09%	-1.88%	-0.17%	+7.86%	-15.06%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEC Alphatec	4.3804 of 5 stars	3.4	1.0	0.0	3.3	3.7	4.2	0.6
INO Inovio Pharmaceuticals	3.8937 of 5 stars	3.3	1.0	0.0	4.4	2.9	0.0	1.3
OSUR OraSure Technologies	1.8223 of 5 stars	1.0	2.0	0.0	4.2	0.0	1.7	0.6
UTMD Utah Medical Products	1.6275 of 5 stars	0.0	2.0	1.7	4.1	0.0	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	2.89	Moderate Buy	$17.89	54.48% Upside
INO Inovio Pharmaceuticals	2.60	Moderate Buy	$8.80	533.09% Upside
OSUR OraSure Technologies	2.00	Hold	$3.00	-1.64% Downside
UTMD Utah Medical Products	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest INO, OSUR, ATEC, and UTMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/9/2025	INO Inovio Pharmaceuticals	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$5.00
6/16/2025	ATEC Alphatec	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Buy	$18.00
5/19/2025	OSUR OraSure Technologies	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	In-Line ➝ In-Line	$3.00 ➝ $3.00
5/14/2025	INO Inovio Pharmaceuticals	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$5.00 ➝ $5.00
5/14/2025	INO Inovio Pharmaceuticals	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$15.00 ➝ $13.00
5/2/2025	ATEC Alphatec	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$13.00 ➝ $15.00
5/2/2025	ATEC Alphatec	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $16.00
4/14/2025	ATEC Alphatec	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$642.27M	2.64	N/A	N/A	($0.10) per share	-115.80
INO Inovio Pharmaceuticals	$283.10K	180.07	N/A	N/A	$1.90 per share	0.73
OSUR OraSure Technologies	$185.83M	1.23	$0.04 per share	78.05	$5.50 per share	0.55
UTMD Utah Medical Products	$40.90M	4.55	$4.93 per share	11.61	$34.62 per share	1.65

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$162.12M	-$1.15	N/A	N/A	N/A	-25.77%	-1,657.19%	-21.53%	7/30/2025 (Estimated)
INO Inovio Pharmaceuticals	-$107.25M	-$3.19	N/A	N/A	N/A	N/A	-136.93%	-89.99%	8/6/2025 (Estimated)
OSUR OraSure Technologies	-$19.50M	-$0.42	N/A	N/A	N/A	-19.77%	-5.86%	-5.20%	8/5/2025 (Estimated)
UTMD Utah Medical Products	$13.87M	$3.78	15.13	∞	N/A	33.00%	10.74%	10.27%	7/24/2025 (Estimated)

Latest INO, OSUR, ATEC, and UTMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	OSUR OraSure Technologies	-$0.15	N/A	N/A	N/A	$30.52 million	N/A
7/30/2025	Q2 2025	ATEC Alphatec	-$0.06	N/A	N/A	N/A	$178.85 million	N/A
5/13/2025	Q1 2025	INO Inovio Pharmaceuticals	-$0.74	-$0.51	+$0.23	-$0.51	$0.01 million	$0.07 million
5/1/2025	Q1 2025	ATEC Alphatec	-$0.12	-$0.35	-$0.23	-$0.35	$167.57 million	$169.18 million
4/29/2025	Q1 2025	UTMD Utah Medical Products	N/A	$0.92	N/A	$0.92	N/A	$9.71 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
INO Inovio Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
OSUR OraSure Technologies	N/A	N/A	N/A	N/A	N/A
UTMD Utah Medical Products	$1.22	2.13%	N/A	32.28%	3 Years

Latest INO, OSUR, ATEC, and UTMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/16/2025	UTMD Utah Medical Products	quarterly	$0.3050	2.3%	6/16/2025	6/16/2025	7/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	N/A	2.75	1.67
INO Inovio Pharmaceuticals	N/A	2.63	2.63
OSUR OraSure Technologies	N/A	12.34	10.94
UTMD Utah Medical Products	N/A	22.29	20.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
INO Inovio Pharmaceuticals	26.79%
OSUR OraSure Technologies	93.50%
UTMD Utah Medical Products	69.60%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	20.90%
INO Inovio Pharmaceuticals	2.30%
OSUR OraSure Technologies	3.90%
UTMD Utah Medical Products	7.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	146.17 million	115.62 million	Optionable
INO Inovio Pharmaceuticals	320	36.67 million	35.83 million	Optionable
OSUR OraSure Technologies	840	74.80 million	71.88 million	Optionable
UTMD Utah Medical Products	180	3.25 million	3.01 million	Not Optionable

INO, OSUR, ATEC, and UTMD Headlines

Recent News About These Companies

Utah Medical Products (NASDAQ:UTMD) Stock Passes Below 200-Day Moving Average - What's Next?

July 9 at 4:53 AM | marketbeat.com

Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest

July 3, 2025 | seekingalpha.com

UTMD Utah Medical Products, Inc. - Seeking Alpha

June 26, 2025 | seekingalpha.com

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

June 26, 2025 | finance.yahoo.com

There May Be Reason For Hope In Utah Medical Products' (NASDAQ:UTMD) Disappointing Earnings

May 23, 2025 | finance.yahoo.com

Utah Medical Products, Inc. Announces Quarterly Dividend | UTMD Stock News

May 6, 2025 | gurufocus.com

Utah Medical Products, Inc. Announces Quarterly Dividend

May 6, 2025 | gurufocus.com

Utah Medical Products, Inc. Announces Quarterly Dividend

May 6, 2025 | accessnewswire.comA

Utah Medical Q1 Earnings Drop 16% on Sales Slump, Stock Up 1%

May 5, 2025 | zacks.com

Utah Medical Products Inc Reports Q1 2025 Earnings: EPS at $0.919, Revenue at $9.71 Million

April 30, 2025 | gurufocus.com

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025

April 29, 2025 | accessnewswire.comA

Latest changes to Utah's medical marijuana law will slash patient fees and add two rural pharmacies

April 23, 2025 | cityweekly.netC

Despite Some Deterioration, Utah Medical Products Is A Solid Play

April 17, 2025 | seekingalpha.com

Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open

April 16, 2025 | seekingalpha.com

Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open

April 16, 2025 | seekingalpha.com

An Unexpected Side-Effect For Utah Medical Products: Recession-Driven Birthrate Declines

April 9, 2025 | seekingalpha.com

Utah Medical Products' (NASDAQ:UTMD) Soft Earnings Are Actually Better Than They Appear

April 7, 2025 | finance.yahoo.com

Utah Medical Products, Inc. (UTM.F)

March 6, 2025 | finance.yahoo.com

Utah Medical Products Faces Challenges Amid Revenue Declines

February 17, 2025 | tipranks.com

Trend Tracker for (UTMD)

February 10, 2025 | news.stocktradersdaily.comN

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.305

February 7, 2025 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Top Stocks Under $20 Riding the “Made in America” Wave
By Chris Markoch | July 3, 2025
View 3 Top Stocks Under $20 Riding the “Made in America” Wave
D-Wave Is Soaring—But Is ETF Diversification the Better Strategy?
By Nathan Reiff | June 11, 2025
View D-Wave Is Soaring—But Is ETF Diversification the Better Strategy?
3 Tech Focused ETFs to Watch as the Market Nears All-Time Highs
By Ryan Hasson | June 11, 2025
View 3 Tech Focused ETFs to Watch as the Market Nears All-Time Highs
Correction Equals Opportunity in Domino’s Pizza Stock
By Gabriel Osorio-Mazilli | July 6, 2025
View Correction Equals Opportunity in Domino’s Pizza Stock
IGM ETF: Expand Tech Exposure With Top AI Leaders
By Jeffrey Neal Johnson | July 1, 2025
View IGM ETF: Expand Tech Exposure With Top AI Leaders

INO, OSUR, ATEC, and UTMD Company Descriptions

Alphatec NASDAQ:ATEC

$11.58 +0.09 (+0.78%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$11.58 +0.01 (+0.04%)

As of 07/10/2025 04:20 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Inovio Pharmaceuticals NASDAQ:INO

$1.39 -0.06 (-4.14%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$1.41 +0.02 (+1.44%)

As of 04:03 AM Eastern

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

OraSure Technologies NASDAQ:OSUR

$3.05 +0.02 (+0.66%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$3.07 +0.02 (+0.52%)

As of 04:00 AM Eastern

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Utah Medical Products NASDAQ:UTMD

$57.21 -0.05 (-0.09%)

Closing price 07/10/2025 04:00 PM Eastern

Extended Trading

$57.18 -0.02 (-0.04%)

As of 07/10/2025 04:04 PM Eastern

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time